Position in VTRS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$3,636,459
+$198,367 QoQ
Shares Held
269,168
-2.5% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MetLife Investment Management, LLC holds $88,544,808 across 37 Drug Manufacturers - Specialty & Generic names. VTRS ranks #8 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SUPN |
Supernus Pharmaceuticals, Inc.
|
304,172 | $15,722,650 | |
| 2 | ZTS |
Zoetis Inc.
|
114,814 | $13,572,162 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
21,171 | $12,553,979 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
53,053 | $6,989,202 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
244,343 | $5,847,127 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
67,088 | $5,088,624 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
211,317 | $4,386,940 | |
| 8 | VTRS |
Viatris Inc
This page
|
269,168 | $3,636,459 |
All Filings in VTRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,636,459 | 269,168 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $3,438,092 | 276,152 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $2,865,099 | 289,404 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,672,409 | 299,262 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $2,699,107 | 309,886 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $3,931,660 | 315,796 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $3,601,677 | 310,222 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $3,375,173 | 317,514 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $3,352,966 | 280,818 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $3,153,132 | 291,148 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,924,692 | 296,622 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $3,036,584 | 304,267 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $3,010,328 | 312,924 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,524,581 | 316,674 | Shares | Defined | 2023-03-23 | |
| 2022-09-30 | $2,742,000 | 321,831 | Shares | Defined | 2023-03-23 | |
| 2022-06-30 | $3,419,166 | 326,568 | Shares | Defined | 2023-03-23 | |
| 2022-03-31 | $3,579,933 | 329,038 | Shares | Defined | 2023-03-23 | |
| 2021-12-31 | $3,615,283 | 267,205 | Shares | Defined | 2023-03-23 | |
| 2021-09-30 | $4,026,680 | 297,172 | Shares | Defined | 2023-03-23 | |
| 2021-06-30 | $4,004,358 | 280,221 | Shares | Defined | 2023-03-23 | |
| 2021-03-31 | $4,359,953 | 312,094 | Shares | Defined | 2023-03-23 | |
| 2020-12-31 | $5,490,632 | 292,990 | Shares | Defined | 2023-03-23 | |
| No filing history on record for this holder in this stock. | ||||||